Triplet Induction + 1 or 2-Drug Maintenance

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Near Add Your Location

Sorting 370 by

Kettering Cancer Care
Kettering, OH
  • Accepting patients
Smilow Cancer Hospital
L+M Waterford Cancer Care Center
Waterford, CT
  • Accepting patients
Geisinger Wyoming Valley Medical Center
Henry Cancer Center
Wilkes-Barre, PA
  • Accepting patients
Rice Memorial Hospital
Willmar, MN
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.